Commission Directive 2010/85/EU [Commission Directive 2010/85/EU of 2 December 2010 amending Council Directive 91/414/EEC to include zinc phosphide as active substance and amending Decision 2008/941/EC (OJ L 317, 3.12.2010, p. 32, ELI: http://data.europa.eu/eli/dir/2010/85/oj).] included zinc phosphide in Annex I to Directive 91/414/EEC as an active substance until 30 April 2021 and it was subsequently included in Part A of the Annex to Implementing Regulation (EU) No 540/2011. The approval of zinc phosphide was extended three times, most recently by Commission Implementing Regulation (EU) 2024/1206 [Commission Implementing Regulation (EU) 2024/1206 of 29 April 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, dithianon, dodine, fluometuron, hexythiazox, isoxaben, lime sulphur, orange oil, prosulfuron, quinmerac, sintofen, sodium silver thiosulfate, tau-fluvalinate, tebufenozide, tembotrione and zinc phosphide (OJ L, 2024/1206, 30.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1206/oj).] until 31 December 2026.
Recital 8, Regulation (EU) 2026/2348
In force
Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulati…Law
- celex=31991L0414
- celex=32010L0085
- num:eu=1991/414